A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

NCT02256150 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: Mizoribine (MZR)
DRUG: Cyclophosphamide (CTX)

Sponsor

Asahi Kasei Therapeutics Corporation